Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters











Publication year range
1.
Med Clin (Barc) ; 92(3): 91-4, 1989 Jan 28.
Article in Spanish | MEDLINE | ID: mdl-2709901

ABSTRACT

We have previously shown that ketoconazole may inhibit the androgen synthesis, but the risk to induce a blockade in the cortisol synthesis and/or hepatic abnormalities makes it mandatory to look for the least dose that is able to inhibit androgen production without inducing other abnormalities. To this end, we studied the levels of 17-alpha-hydroxyprogesterone (17, alpha-OH-P), dehydroepiandrosterone sulphate (DHEA-S), delta 4-androstenedione (delta 4-A), total (tT) and free (fT) testosterone, and the cortisol response to ACTH in 13 women with hyperandrogenism, before and after ketoconazole therapy at dosages of 400, 600, and 800 mg/day. Although with the 400 mg regimen a reduction in the levels of androstenedione and free and total testosterone was already observed, it was of small amount and it was not until the 600 mg regimen that androgen levels became normal. Thus, DHEAS-S was reduced from 3.672 +/- 1.013 to 2.216 +/- 756 ng/ml (p less than 0.05); delta 4-A was reduced from 392 +/- 80 to 283 +/- 79 ng/ml (p less than 0.01); tT was reduced from 1.5 +/- 0.78 to 0.7 +/- 0.1 ng/ml (p less than 0.05), and fT from 5.5 +/- 1.0 to 2.7 +/- 1.3 pg/ml (p less than 0.001). By contrast, 17 alpha-OH-P increased from 1.7 +/- 1.3 to 4.7 +/- 1.3 ng/ml (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Androgens/blood , Hydrocortisone/metabolism , Ketoconazole/pharmacology , Adolescent , Adult , Androgens/metabolism , Dose-Response Relationship, Drug , Female , Humans , Hydrocortisone/biosynthesis , Ketoconazole/administration & dosage , Testosterone/blood
3.
Med Clin (Barc) ; 75(7): 292-5, 1980 Oct 25.
Article in Spanish | MEDLINE | ID: mdl-7432036

ABSTRACT

Three siblings consulted because of hypogonadism. Physical examination revealed absence of secondary sexual characteristics and infantile genitalia. Increased serum concentrations of LH and FSH were found with abnormal high response to the stimulus with 100 Ug LH-RH. Plasma testosterone concentrations were 0.7, 0.5, and 0.3 ng/ml, respectively; no change in these values was observed after administering 5.000 UI HCG per day during 1 week. Patients underwent a laparotomy but no testicular tissue remnants were found. Whether vascular anomalies, trauma, infectious processes or other factors are responsible is not known. The possibility that genetic abnormalities could be involved in the pathogenesis of this entity is suggested.


Subject(s)
Hypogonadism/genetics , Adult , Child , Diseases in Twins/genetics , Humans , Infant , Male
5.
Rev Iber Endocrinol ; 23(135): 239-61, 1976.
Article in Spanish | MEDLINE | ID: mdl-951556

ABSTRACT

We have studied the effect of the i.v. administration of 1 g tolbutamide upon glycemia, insulinemia and serotoninemia in normal subjects and obese patients. We have seen an elevation of the last two variables in direct relationship with the previous blood sugar levels. The baseline serotonin level in obese people is higher than in normals, but the tolbutamide induced elevation is of a lesser magnitude. We believe this fact is due to the competitive action of insulin, as our obese patients have shown to have a "hyperinsulinism" with "disinsulinism".


Subject(s)
Obesity/blood , Serotonin/blood , Tolbutamide , Female , Humans , Injections, Intravenous , Male , Serotonin/metabolism , Tolbutamide/administration & dosage , Tolbutamide/blood
6.
Rev Iber Endocrinol ; 23(135): 263-73, 1976.
Article in Spanish | MEDLINE | ID: mdl-951557

ABSTRACT

Growth hormone (GH) secretion was studied in a group of alut controls and a series of patients with primary hypothyroidism before and after treatment with thyroid hormones. Intravenous insulin-induced hypoglycemia was the stimulus used (0,1 UI/kg body weight). It is concluded that in primary hypothyroidism, GH secretion is almost absent due to relative inactivity of the somatotropic cells and/or lack of GH-RH. This decreased secretory response becomes rapidly normal after treatment with physiological doses of thyroid hormones.


Subject(s)
Growth Hormone/metabolism , Hypothyroidism/metabolism , Thyroid Gland/metabolism , Thyroid Hormones/therapeutic use , Adolescent , Adult , Drug Evaluation , Female , Humans , Hypothyroidism/drug therapy , Male , Secretory Rate
SELECTION OF CITATIONS
SEARCH DETAIL